A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

Journal of Clinical Investigation

Volumn 107, Issue 7, 2001, Pages 853-860

  Pennathur, Subramaniam ^a   Wagner, Janice D ^b   Leeuwenburgh, Christiaan ^a,d   Litwak, Kenneth N ^b,e   Heinecke, Jay W ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Box 8046   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; GLYCOSYLATED HEMOGLOBIN; HYDROXYL RADICAL; NITROGEN; PROTEIN DERIVATIVE; STREPTOZOCIN; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY WALL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HYPERGLYCEMIA; MALE; MONKEY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0035057229     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11194     Document Type: Article

References (47)

1. The mystery of diabetes and atherosclerosis: Time for a new plot
2. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
3. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
5. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study
6. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
7. Hyperglycemic pseudohypoxia and diabetic complications
8. Cytosolic NADH/NAD supply, free radicals and vascular dysfunction in early diabetes mellitus
9. Diabetic microvascular complications and growth factors
10. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy
11. Advanced protein glycosylation in diabetes and aging
12. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging
13. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus
14. The role of oxidized lipoproteins in atherogenesis
15. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall
16. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
17. Advanced glycosylation end-products in tissue and biochemical basis of diabetic complications
18. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo
19. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
20. Structure elucidation of a senescence cross-link from human extracellular matrix: Implication of pentoses in the aging process
21. Pentosidine formation in skin correlates with the severity of complications in individuals with long-standing IDDM
22. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose
23. Pathways of formation of glycoxidation products during glycation of collagen
24. Glucose autoxidation and protein modification: The potential role of autoxidative glycosylation in diabetes
25. Protein glycation and oxidative stress in diabetes mellitus and aging
26. Age-dependent accumulation of ortho-tyrosine and methionine sulfoxide in human skin collagen is not increased in diabetes: Evidence against a generalized oxidative stress in diabetes
27. Accumulation of Maillard reaction products in skin collagen in diabetes and aging
28. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys
29. Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: Changes in carbohydrate metabolism, skin glycation, and pancreatic islets
30. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes. A chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase
31. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease
32. Novel route to peroxynitrite anion
33. Mechanism of carbon dioxide-catalyzed oxidation of tyrosine by peroxynitrite
34. Carbon dioxide: Physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant?
35. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation end products in bovine endothelial cells
36. The advanced glycation end product, N-epsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions
37. Carboxymethylethanolamine: A biomarker of phospholipid modification during the Maillard reaction in vivo
38. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
39. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes
40. Transition metal ions within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein by macrophages
41. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activity in human atherosclerotic material
42. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: Relevance to diseases of glycoxidative stress
43. Free radicals generated during the glycation reaction of amino acids by methylglyoxal
44. Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation
45. Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
46. Advanced glycosylation end-products block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus
47. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications